Imaging: When to get MRI, CT or PET-CT?

Similar documents
AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

The many faces of extranodal lymphoma

C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical Center NewYork Presbyterian Hospital

Neuroradiology Case of the Day

Neck Imaging Reporting and Data System: An Atlas of NI-RADS Categories for Head and Neck Cancer

AJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx

RADIOLOGY TEACHING CONFERENCE

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Case Studies in the Skull Base

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Nasopharyngeal Carcinoma. Rusty Stevens, MD Christopher Rassekh, MD

(loco-regional disease)

Case Scenario #1 Larynx

Perineural Tumor Spread. In Head & Neck Cancer

Sinonasal Tumors. Objectives. Objectives. Incidence of Paranasal Sinus Tumors. Demographics of Paranasal Sinus Tumors. Paranasal Sinus Tumors

Oral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi

Imaging in gastric cancer

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

AJCC update Disclosures. AJCC TNM staging system. Objectives:

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???

Learning Objectives. Head and Neck Cancer: Post-Treatment Changes. Neck Dissection Classification * Radical neck dissection. Radical Neck Dissection

You Can t Avoid Errors

PILOT STUDY OF CONCURRENT CHEMO-RADIOTHERAPY FOR ADVANCED NASOPHARYNGEAL CARCINOMA (Forum for Nuclear Cooperation in Asia)

Management of Salivary Gland Malignancies. No Disclosures or Conflicts of Interest. Anatomy 10/4/2013

Radiology Pathology Conference

Evaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient

PET/CT F-18 FDG. Objectives. Basics of PET/CT Imaging. Objectives. Basic PET imaging

JOSE FRANCISCO GALLEGOS HERNANDEZ Hospital de Oncología, CMN SXXI. IMSS México City.

PET/CT Frequently Asked Questions

Catholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.

L ARYNX S TAGING F ORM

The following images were all acquired using a CTI Biograph

NI-RADS: Structured Reporting for Head and Neck Cancer

NASOPHARYNX MALIGNANT NEOPLASM MOHAMMED ALESSA MBBS, FRCSC ASSISTANT PROFESSOR, CONSULTANT OTOLARYNGOLOGY, HEAD & NECK SURGRY KING SAUD UNIVERSITY

ARTICLE. Imaging the cranial nerves in cancer

Anatomy of Head of Neck Cancer

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Imaging of Pediatric MSK Tumors

New Visions in PET: Surgical Decision Making and PET/CT

Merkel Cell Carcinoma Case # 2

Clinical indications for positron emission tomography

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina

CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER

Compartmentalization of the larynx Sites and subsites Supraglottis Glottis subglottis Spaces Pre-epiglottic epiglottic space Para-glottic space

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

1. Resident Doctor, 2. Professor, Geetanjali Medical College & Hospital, Udaipur, Rajasthan.

TEDDY PET/CT AT THE U OF U READY FOR THE UNCLEAR MEDICINE? Case #1. Case #1 60 y/o male with MGUS, PET/CT to evaluate for active multiple myeloma

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

Cancer of the Oral Cavity

Nasal Cavity CS Tumor Size (Revised: 02/03/2010)

2. Guidelines for Reporting Head and Neck Tumours

Unknown Cases from the Participants

Clinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Surgery in Head and neck cancers.principles. Dr Diptendra K Sarkar MS,DNB,FRCS Consultant surgeon,ipgmer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

MALIGNANT TUMOURS OF THE JAWS

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Head and Neck Pathology. Macroscopy and Dissection Dr Tim Bracey Consultant Pathologist (Derriford Hospital)

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Lymphoma Read with the experts

Imaging Work-Up of a Neck Mass - Adults & Children

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Katsuro Sato. Department of Speech, Language and Hearing Sciences, Niigata University of Health and Welfare, Niigata, Japan

Perineural Tumor Spread (PNS) Perineural Tumor Spread (PNS) PNS Anatomic Considerations. Perineural Tumor Spread-Imaging

Treatment for Supraglottic Ca History: : Total Laryngectomy y was routine until early 50 s, when XRT was developed Ogura and Som developed the one-sta

Prostate Case Scenario 1

Laurie A. Loevner, MD

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY

Neuroradiology MR Protocols

NI-RADS: Head & Neck Cancer Imaging Surveillance. Goals of the RADS templates: Goals: Disclosures ACR NI-RADS

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Abdominal applications of DWI

Nasopharyngeal Cancer. Nasopharynx: Anatomy. Disclosures. Objectives. Head and Neck Cancer I. Thank you. Nasopharynx

An Introduction to PET Imaging in Oncology

Salivary Glands tumors

Organ preservation in laryngeal cancer

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

ESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018

What is ACC? (Adenoid Cystic Carcinoma)

CT PET SCANNING for GIT Malignancies A clinician s perspective

Survey of Laryngeal Cancer at SBUH comparing 108 cases seen here from to the NCDB of 9,256 cases diagnosed nationwide in 2000

Guidelines for the Management of Head and Neck Cancer

LYMPHATIC DRAINAGE IN THE HEAD & NECK

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Head & Neck Contouring

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

MANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

A220: Larynx cancer tissues. (formalin fixed)

IMPACT OF MAGNETIC RESONANCE IMAGING VERSUS CT ON NASOPHARYNGEAL CARCINOMA: PRIMARY TUMOR TARGET DELINEATION FOR RADIOTHERAPY

From GTV to CTV: A Critical Step Towards Cure. Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017

Thoracic Recurrences. Soft tissue recurrence

Transcription:

Imaging: When to get MRI, CT or PET-CT? Alina Uzelac, D.O. Assistant Clinical Professor Neuroradiology UCSF Department of Radiology and Biomedical Imaging San Francisco General Hospital Overview CT MRI PET-CT Advanced Imaging Techniques 1

Imaging Studies Initial Assessment Head and Neck Ca: degree of local infiltration regional lymph nodes involvement presence of distant metastases second primary tumors Local Infiltration/Tumor Extent 2

Orbital and Intracranial Extension Sinonasal Undifferentiated Carcinoma Ax CT Inseparable medial rectus muscle 59 F w/ trauma. Orbital and Intracranial Extension Sinonasal Undifferentiated Carcinoma Floor of anterior cranial fossa Medial rectus Cor CT 3

CT or MRI All Pts. initial staging MRI or CT for HEAD and NECK SCCa. particularly useful in Pts. with clinically N0 neck. CT vs MRI CT and MRI are complementary to the clinical examination. and may also be complementary to each other. 4

33 M with an inverted papilloma degenerated into SCCa CT = superior for cortical bone erosion Bone window Ax CT w/ Local Invasion Paraglottic fat extension 56 F w/ epiglottic mass 5

CT versus MRI? Ax CT w/ CT Ax T1 MRI Preepiglottic Space Extension Base of Tongue SCCa CT versus MRI? Preepiglottic Space Extension Supraglottic SCCa Sag CT w/ CT Sag T1 Motion MRI 6

Prevertebral Extension Pyriform Sinus SCCa Imaging Studies Initial Assessment Head and Neck Ca: degree of local infiltration regional lymph nodes involvement presence of distant metastases second primary tumors 7

CT versus MRI? Small Abnormal LNs Ethmoid Sinus SCCa Recurrence Preserved fatty hilum Thickened cortex 8

PET-CT Clinical N0 neck can be PET negative, given small node volume (<1mL). PET-CT Tongue SCCA Ax CT Small LN for PET 9

Thyroid Cartilage Invasion Laryngeal SCCa Ax CT w/ Ax CT w/ CT adequate for ossified cartilage Thyroid Cartilage Invasion Laryngeal SCCa Ax T1 Ax T1 w/ Gd MRI superior for marrow infiltration 10

Thyroid Cartilage Invasion Laryngeal SCCa Loss of nl fat bright signal Abnormal enhancement Ax T1 Ax T1 w/ Gd MRI superior for marrow infiltration Thyroid Cartilage Invasion Laryngeal SCCa Loss of fat suppression Ax T2 MRI superior marrow infiltration 11

33 M w/ sinonasal SCCa s/p resection returns w/ brain abscess MRI Cor T2 MRI Cor T1 w/ MRI > CT for distinguishing malignancy from mucus SCCa recurrence MRI Cor T2 MRI Cor T1 w/ MRI > CT for distinguishing malignancy from mucus 12

SCCa recurrence ax CT w/ cor CT w/ Returns w/ erythema and swelling Ax CT SCCa recurrence perineural spread cavernous sinus 13

MRI over CT Perineural spread of tumor (use thinner slice thickness - 3 mm) Intracranial extension Nasopharyngeal Ca (initial staging and follow up). Intracranial Extension Nasopharyngeal Ca bone erosion along vidian canal Ax T1 w/ ax CT 14

Intracranial Direct Extension SNUC Dural invasion Cor T1 Gd MRI Staging of NPC 15

PET-CT? Routine PET for initial staging, unless: Equivocal findings on CT or MRI. High risk of distant metastatic disease. Search for 2 nd primary. Nodal SCCa unknown primary. PET-CT To be done before Bx: Guide to area of highest yield Bx can result in high uptake. 16

PET-CT Superior to CT Cor PET- CT ax CT Cricoid Cartilage Invasion Subglottic SCCa Treatment Response MRI PET-CT Done 3 months post treatment completion (prevent false positives). 17

Nonsurgical Treatment Response - radiologic resolution = cure - reduction in size < 50% = failure - 50 75% reduction = indeterminate (close surveillance) Advanced Imaging Techniques Predicting Tumor Response PET: High SUV = poor response Diffusion (DWI) MRI. Dynamic perfusion MRI (vs CT): Tumor hypoxia = radioresistance (and chemoresistance). Increased tumor perfusion => improved locoregional control. 18

MRI Diffusion Weighted Sequence for Tx response prediction ax DWI ax ADC Nodal metastasis Staging MRI tongue SCCa MRI Diffusion Weighted Sequence for Tx response Staging MRI Follow up ax DWI ax DWI Nodal metastasis resolution of abnl diffusion = Tx response 19

Recurrence Imaging MRI (extent of tumor) PET-CT (metastases) MRI Diffusion Weighted Sequence for recurrence ax DWI ax ADC Hx mod diff SCCa tongue p-hemiglossectomy, chemort, followed by LND. Recurrence, then radical neck dissection w/ pectoralis flap. 20

Recurrence MRI for extent of tumor 52 M w/ Hx NPCA s/p XRT in China 4 years prior Recurrence PET for metastases 35 M presents with back pain 2 years after NPC treatment Solitary NPC metastasis biopsy-proven. 21

Recurrence PET for flap flap 64-year-old male status post left total maxillectomy and free ALT flap for SCCa, post chemo and radiation therapy. Treatment Complications Imaging Complications occasionally incidentally imaged. MRI PET-CT 22

Post XRT Complications Skull base XRT changes PET negative 44yo s/p XRT for NPC. Post XRT Complications Skull base XRT changes PET negative 44yo s/p XRT for NPC. 23

Post XRT Complications Ax T1 w/ Gd Cor FLAIR Bitemporal XRT necrosis Post XRT Complications No abnormal hypermetabolism Ax T1 w/ Gd Cor FLAIR Ax PET Bitemporal XRT necrosis 24

Post XRT Complications Brain necrosis 5 years post XRT for NPC Post XRT Complications Ax Gd perfusion Bitemporal XRT necrosis 25

Oxaliplatin and CyberKnife Completed 07/2013 for recurrent NPC Returns 12/2013 w/ L jaw pain and trismus Oxaliplatin and CyberKnife Completed 07/2013 for recurrent NPC XRT necrosis central skull base and nasopharynx 26

Acute Muscle Denervation P-XRT Masticator mm. acute denervation XRT necrosis central skull base and NP PET Pitfall Acute Muscle Denervation = High Uptake Right extraocular mucles acute denervation 27

PET Pitfall Acute Muscle Denervation = High Uptake Right extraocular mucles acute denervation 84 M recurrent parotid malignancy perineural spread cavernous sinus. Whole Body PET-MRI 28

Siemens integrated PET-MRI = simultaneous imaging = superior registration Whole Body PET-MRI PET-MRI Siemens integrated PET-MRI = simultaneous imaging = superior registration 29

TAKE HOME POINTS Head and Neck Ca Imaging Initial Staging: CT or MRI. MRI for NPC Consider PET-CT: Distant metastases Positive neck nodes without identifiable primary Look for second primary TAKE HOME POINTS Head and Neck Ca Imaging Predicting response ADVANCED imaging: MRI Diffusion and Perfusion tumor oxygenation PET MRI-PET! 30

TAKE HOME POINTS Head and Neck Ca Imaging Surveillance: MRI Recurrence: MRI and PET Thank you! alina.uzelac@ucsf.edu 31